Recent Press Releases & News
QNRX earnings at a glance
Quoin Pharmaceuticals, Ltd. (QNRX) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. Analysts expect earnings per share of -$1.88, compared with -$6.71 in the same quarter last year (+72%). Over its last 6 reports the stock rose the next day 4 times and fell 2, moving ±6.1% on average; after the most recent report on Aug 14, 2026 it moved +2.0%. QNRX beat the consensus EPS estimate in 2 of its last 6 reported quarters. The share price of $4.01 sits near its 52-week low.
Overview
Earnings trends
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri Aug 14, 2026 | Jun/2026 | $-1.90 | $-1.83 | -3.8% | +70.9% | +2.0% | earnings |
| Thu May 7, 2026 | Mar/2026 | $-1.77 | $-1.80 | +1.7% | +72.8% | -6.9% | earnings |
| Thu Mar 26, 2026 | 8K 2026-03-26 | $-14.80 | $-6.42 | -130.5% | — | -18.4% | earnings |
| Thu Nov 6, 2025 | Sep/2025 | $-6.71 | $-6.36 | -5.5% | — | +5.1% | earnings |
| Thu Aug 7, 2025 | Jun/2025 | $-6.28 | $-6.83 | +8.1% | — | +3.5% | earnings |
| Tue May 13, 2025 | Mar/2025 | $-6.50 | $-3.85 | -68.8% | — | +0.7% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Nov 5, 2026 | Sep/2026 | OTHER | -$1.88 | -$6.71 | +72.0% |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $-5M | $-5M | — | $-4M | $-4M | $-4M | — | $-2M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4M | $3M | $4M | $2M | $2M | $4M | $4M | $3M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $12M | $15M | $20M | $6M | $8M | $12M | $15M | $10M |
| Total assets | $12M | $16M | $20M | $6M | $9M | $13M | $16M | $11M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $8M | $7M | $7M | $8M | $6M | $7M | $7M | $6M |
| Total equity | $4M | $9M | $13M | $-1M | $3M | $6M | $9M | $5M |
Implied volatility — last 90 days
No IV snapshots yet for QNRX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
QNRX earnings FAQ
When is QNRX's next earnings date?
Quoin Pharmaceuticals, Ltd. is expected to report on November 5, 2026.
How does QNRX stock usually react to earnings?
Across the last 6 reports the average next-day move was ±6.1%, up 4 times and down 2 times.
What EPS are analysts expecting from Quoin Pharmaceuticals, Ltd.?
The consensus estimate is -$1.88 per share, versus -$6.71 a year ago.